DENVER, Sept. 11, 2020 /PRNewswire/ — A recent Data Bridge Market Research report notes that the once-hot cannabis industry looks to be heating up again — in a big way. The report includes predictions that the global legal marijuana market will total more than $90 billion by 2027. Smart companies are jostling for a strong position in this explosive space, looking to leverage their expertise to capitalize on opportunities the multi-billion-dollar sector provides. Recognizing key challenges in the industry, including the availability of the often subpar quality of the available product along with the high cost of development and land acquisition, Pac Roots Cannabis Corp. (CSE: PACR) (PACR Profile) is focusing on its state-of-the-art genetics to ensure production of premium-quality products. The company also relies on science and critical strategic partnerships to eliminate quality and cost barriers to success. In addition, Cresco Labs Inc (CSE: CL) (OTCQX: CRLBF)  has received regulatory approval to acquire one of 10 vertically integrated licenses in New York.

In contrast, Tilray Inc. (NASDAQ: TLRY) has received complete GMP certification at its EU campus. Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) has almost completed the first phase of a business transformation focused on setting up the company for success in this burgeoning space. And in the medical-use sector, Arena Pharmaceuticals Inc. (NASDAQ: ARNA) is pursuing a significant unmet opportunity for a targeted IBS pain treatment using olorinab, a peripherally acting, highly selective, full agonist of the cannabinoid receptor 2 (CB₂).

• Absolute access to one of Canada’s largest live genetic cannabis libraries provides PACR with more than 350 lab-tested, field-tested cultivars.
• Superior flowers are key to producing superior cannabis products.
• Pac Roots chooses the best outdoor growing climates in Canada for its growing cultivation operations.

Click here to view the Pac Roots Cannabis Corp’s custom infographic (CSE: PACR) editorial.

Promising Potential in Multi-Billion-Dollar Cannabis Industry

Delivering the Best

While it may seem obvious, the availability of high-quality flowers is essential to the process of producing high-quality cannabis products. Yet as demand for cannabis products has increased and more companies have entered the flourishing space, the quality of raw cannabis products may be slipping as companies focus more on market share than quality.

Pac Roots Cannabis Corp. (CSE: PACR) is committed to delivering the finest cannabis genetics to its customers, preserving the superiority of its carefully cultivated elite strains while also working to introduce unmatched new strains. While some companies may work to be the largest cannabis grower, Pac Roots believes that product quality is paramount. Pac Roots is dedicated to becoming a leader in the premium-cannabis space, with demand for premium products at an all-time high.

The company achieves this objective in part through its strategic licensing agreement with Phenome One Corp, which gives Pac Roots complete access to one of Canada’s largest live genetic cannabis libraries with both fields- and lab-tested, selectively bred cultivars. Pac Roots utilizes the Phenome One library cultivars to grow, breed, and clone its distinctive brands. As a result, Pac Roots offers everything from CBD-dominant plants with rare terpene profiles and soaring 30%-plus THC giants to West Coast outdoor, botrytis-resistant plants through vigilant breeding and cultivation.

Pac Roots and Phenome One are developing exclusive strains with several beneficial characteristics. The impressive catalog consists of more than 350 tested cultivars; approximately 50 are in the super-elite category. The partnership aims to offer the highest-quality cultivars that have been proven and tested under variable commercial conditions to provide the greatest resilience. In addition, the two companies share a dedication to delivering rich THC and CBD cultivars with unique terpene profiles while continuing to attain industry-leading GPW yields.

Key to Quality Cannabis

Superior genetics isn’t the only key to cultivating quality cannabis. Optimized farming systems are crucial in the pursuit of quality products. Pac Roots works closely with carefully selected partners to improve cultivation through proprietary methods, including the following fundamental components:

• Nutrients are custom formulated from raw salts for specific cultivars.
• Systematic planting of young, hardy cultivars, measuring up to 18 inches, provides maximum growth and resilience.
• Row compaction and mowing for weed control, enabling a selected harvest
• Complex irrigation systems with direct-nutrient and spring-water delivery to each plant site.

In addition to observing tested and refined cultivation methods, Pac Roots carefully selected its cultivation sites. They focused its operations on Canada’s finest outdoor growing climates, including the South Okanagan Valley and the Fraser Valley Regional District.

Golden Mile Cultivation

Known as the Golden Mile and now referred to as the Napa Valley of the North, the South Okanagan Valley in British Columbia is Rock Creek Farms, a 100-acre, premium-hemp joint venture Pac Roots started in May 2020 after receiving its hemp cultivation license from Health Canada.

Planting began in June when approximately 130,000 premium-hemp CBD seedlings, which had been sown earlier in greenhouses to ensure optimum growth and reduce environmental impact, were systematically planted across two 50-acre parcels. With harvesting projected to begin in October, the hemp plantation crop is expected to be between 500,000 and 700,00 pounds of biomass; 100% of that yield is already under contract with a processor at fair market value.

“It has been busy for months since listing on the CSE in early May 2020,” said Pac Roots CEO Patrick Elliott. “We are proud to have a healthy crop and remain bullish on delivering a premium, high-yielding product to our customer. In early 2020, we had a goal of becoming a revenue generator 2020 as market appetite was evolving towards a cash flow scenario and realizing projected forecasts as paramount to survival in this industry. We are privileged to be involved with our strategic partners at Rock Creeks Farms, Phenome One, and Speakeasy Cannabis Club as a production scenario in our first year of operation would not have been possible without the generous leasing of land, equipment, licenses, infrastructure, genetics, operations team, management and expertise to round off the joint venture.”

Fraser Valley Production

The company is also slated to complete a share purchase agreement of 250 acres of prestigious land in the Fraser Valley Regional District (FVRD) of British Columbia. The deal, made with 1088070 BC. Ltd., outlines Pac Roots’ plans to acquire all of the issued and outstanding shares of 1088, which owned nine parcels of pristine property in FVRD, one of the most productive and intensively farmed areas in Canada. The area offers the finest soil, a favorable climate, ample water, and a local market of an estimated 2.5 million people. Agriculture in this region yields an annual economic value of more than $3 billion.

“The addition of such a substantial package of land to our portfolio is a major step for Pac Roots,” said Elliott. “We are pleased to have the opportunity to add significant acreage with an acquisitional cost base of $9,600 per acre. In addition, this land has no zoning restrictions and is not situated within the Agricultural land reserve, which provides for infinite development possibilities.”

The acquisition of the 250 FVRD acres combined with the 100-acre hemp joint venture in Rock Creek and the company’s plans for an indoor cultivation facility in Lake Country, British Columbia, demonstrates a long pipeline of development projects for Pac Roots. Through these recent achievements, the growing company is confirming its ability to optimize cultivation with seasoned expertise. In addition, its commitment to maximizing yield while lowering production costs seems evident throughout Pac Roots’ strategic growth plan.

With demand for superior cannabis products only expected to increase as large-scale growers appear incapable of delivering a premium-grade flower, Pac Roots looks to have firmly established its focus on offering the best crops available and developing future genetics. “Preserving the excellence of our elite strains while introducing the highest quality of new strains to the public is our passion,” the company’s website declares, and its recent activity in the cannabis market looks to support that mission.

Becoming Cannabis Players

While Pac Roots is distinctive in its approach and commitment to quality, it isn’t the only company vying for market share in the flourishing cannabis sector.

Cresco Labs (CSE: CL) (OTCQX: CRLBF) announced that it had received regulatory approval for its acquisition of 100% of the membership interests of Gloucester Street Capital, the parent entity of Valley Agriceuticals LLC, via a merger between Gloucester and an indirect subsidiary of Cresco Labs. Valley Agriceuticals holds one of the ten vertically integrated cannabis business licenses granted in the State of New York by the New York State Department of Health. Each license gives the operator the right to operate one cultivation facility and four dispensaries in New York. The acquisition is expected to close by the end of August.

Aurora Cannabis Inc. (NYSE: ACB) (TSX: ACB) recently released an update on its business operations, including the announcement of a new CEO, Miguel Martin. “Over the last six months, Aurora has focused on building the infrastructure and capabilities necessary for a successful and diversified business,” said Aurora executive chairman and interim CEO Michael Singer. “The first phase of our business transformation, which is now substantially complete, included the rationalization of our cost structure, reduced capital spending, and a more prudent and targeted approach to capital deployment. As a result, we now have a far more efficient asset base and infrastructure to supply our key global markets. I am delighted to now be transitioning the CEO responsibilities to Miguel, and I am confident that Aurora is in a strong position to succeed under Miguel’s leadership.”

Tilray Inc.’s (NASDAQ: TLRY) wholly-owned subsidiary Tilray Portugal Unipessoal Lda. has received a Good Manufacturing Practice (GMP) certification by European Union standards facility in Cantanhede, Portugal. The certification expands the company’s international export capacity to serve authorized medical cannabis markets. It provides authorization to complete medical cannabis extraction on-site and produces bulk extracts to manufacture medical cannabis oil as a finished product. The certification signals another milestone for Tilray’s EU campus, which serves as its international medical cannabis hub.

Another player in the medical space is Arena Pharmaceuticals Inc. (Nasdaq: ARNA). The company has recognized a significant unmet opportunity for a targeted IBS pain treatment. It is involved in Phase 2, placebo-controlled, parallel-group study to evaluate the safety, tolerability, and efficacy of Florina in patients with irritable bowel syndrome who are experiencing abdominal pain.

In an industry anticipated topping $90 billion by 2027, companies operating in the cannabis space’s strategic steps appear to reinforce the sector’s promising future. Companies that focus on high-quality products through genetics while controlling costs could reap outsized market rewards as the industry continues to grow and mature.

For more information about Pac Roots, please visit Pac Roots Cannabis Corp. (CSE: PACR).

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to serve the best private and public companies that desire to reach a broad audience of investors, consumers, journalists, and the general public. CNW has an ever-growing distribution network of more than 5,000 critical syndication outlets across the country. By cutting through information overload in today’s market, CNW brings its clients unparalleled visibility, recognition, and brand awareness. CNW is where news, content, and information converge.

Promising Potential in Multi-Billion-Dollar Cannabis Industry

Cannabis Job Board